Veena Singh, Biocept's Sr VP & Sr Med Director, recently acquired 10,000 shares of the company. The buys took place at $1.10 per share, on October 19, 2016. Singh now owns 28,333 shares of the company. Singh operates out of San Diego, CA. Some additional info was provided as follows:
Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 33,334 fewer shares.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's spouse's ownership of 3,333 fewer shares.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Biocept Announces Pricing Of Public Offering Of Up To 4,925,936 Shares Of Common Stock - Dec. 6, 2017
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Dec. 6, 2017
Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Dec. 6, 2017
General form for registration of securities under the Securities Act of 1933 - Nov. 21, 2017